Login / Signup

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.

Emilien BillonGwenaelle GravisArnaud GuilleNadine CarbucciaJose AdelaideSéverine GarnierPascal FinettiEmilie DenicolaïPatrick SfumatoSerge BrunelleJeanne Thomassin-PianaGéraldine PignotJochen WalzChristian ChabanonJihane PakradouniRenaud SabatierCécile VicierCornel PopoviciEmilie MamessierAnthony GoncalvesDaniel BirnbaumMax ChaffanetFrançois Bertucci
Published in: Cancers (2022)
the profiling of a newly biopsied tumor sample identified AGA in 59% of patients with AUC, led to "matched therapy" in 19%, and provided clinical benefit in 8%.
Keyphrases
  • clinical trial
  • single cell
  • open label
  • phase ii
  • study protocol
  • double blind
  • stem cells
  • phase iii
  • young adults
  • cell therapy
  • smoking cessation